Symyx Technologies Inc

Symyx Technologies — Merger or Acquisition (May 2010)

22 slides from Symyx Technologies's merger presentation, May 27, 2010

  1. Slide 1: Accelrys, Inc. Investor Presentation May 2010

    Accelrys, Inc. Investor Presentation May 2010 Max Carnecchia, CEO Michael Piraino, CFO

  2. Slide 2: Safe Harbor Information

    Safe Harbor Information Safe Harbor Provisions When used in this presentation, words such as expects, believes, anticipates, estimates, and similar expressions identify forward-looking statements. Forward-looking statements may include statements relating to our growth strategy, the future size of o

  3. Slide 3: Investment Summary

    Investment Summary • Creates the leading enterprise scientific informatics software company • Provides the unparalleled capability of managing end-to-end scientific workflows to achieve better outcomes • Deep expertise in chemistry, biology and materials science creates a sustainable competitive adv

  4. Slide 4: Market Environment

    Market Environment

  5. Slide 5: Scientific R&D Challenges Balance Innovation, Automation, Collaboration

    Scientific R&D Challenges Balance Innovation, Automation, Collaboration Scientific innovation is not the only route to higher R&D productivity. Attention to the familiar management areas of cost, speed, and decision making can still reap rewards. Eric David, Tony Tramontin, and Rodney Zemmel McKinse

  6. Slide 6: Today's Research & Development Challenge

    Today’s Research & Development Challenge Drive Top Line Growth Drive Increased Profitability More Innovation • Increase R&D Success Rate – Re-Use Corporate Knowledge – Improve Data Modeling and Simulations – Increase Time Available for Experiments Better Productivity • Increase R&D Efficiency – Redu

  7. Slide 7: Merger with Symyx

    Merger with Symyx

  8. Slide 8: Combining Industry Leaders

    Combining Industry Leaders Founded: Public: ACCL (NASDAQ) FY Revenue: $83.0M Leading positions in: Data Collection and Analysis Data Access, Integration & Transformation Scientific Modeling and Simulation Workflow Automation and Optimization Employees: Headquarters: San Diego, CA Operations: NA, EME

  9. Slide 9: Industry Leading Scientific Informatics Platform

    Industry Leading Scientific Informatics Platform Scientific Desktop Decision Support Analytics Reporting, Visualization & Collaboration Workflow Automation Scientific Information Management Head of IT & Informatics R&D Manager Scientists VP of R&D Numeric Chemistry Chemistry Text Mining Image Analys

  10. Slide 10: With Global Brand Customer Portfolio and Minimal Product Overlap

    With Global Brand Customer Portfolio and Minimal Product Overlap Accelrys + Symyx has over 1,350 total, unique customers including • 29 of the top 30 biopharmaceutical companies • 5 of the top 5 chemical companies • 5 of the top 5 aerospace companies • 3 of the top 5 CPG companies • And major Govern

  11. Slide 11: Scientific Informatics Software System and Partner Ecosystem

    Electronic Lab Notebook Scientific Information Management Decision Support And Analytics Workflow Automation Reporting, Visualization And Collaboration Scientific Informatics Software System Vibrant & Growing Partner Ecosystem Additional applications and solutions developed by partner community More

  12. Slide 12: Revenue Growth Drivers

    Revenue Growth Drivers

  13. Slide 13: Revenue Growth Drivers

    Revenue Growth Drivers • New scientific markets • Biology/BioReg • Scientific Informatics Platform - Pipeline Pilot 8.0 • ELN – Symyx Notebook 6.4 • Professional services

  14. Slide 14: Pipeline Pilot

    Pipeline Pilot • Enterprise Scientific Data Pipelining Platform • Data collection and Integration • Analysis • Visualization • Application Deployment • Capabilities • Integration of diverse data and applications • Automated scientific data analysis and processing • Capture and deployment of best-pra

  15. Slide 15: 2010 Symyx Market Position by Domain

    ELN/ELE No. 1 Market Position No. 2 or 3 Market Position DMPK* Market Position 2010 Symyx Market Position by Domain INTRODUCTION GROWTH MATURITY 50% Product Life Cycle Stage DMPK* Formulations Bioanalytical Pharmacology Process Chemistry Synthetic Chemistry *Addressed through partnership with Symyx

  16. Slide 16: Deal Terms & Financials

    Deal Terms & Financials

  17. Slide 17: Terms of Deal

    Terms of Deal Merger Agreement Closing Exchange Ratio Ownership Market Capitalization Cash Position Approvals Expected Synergies HQ Employees Leadership Board Membership Tax-free, all stock merger of equals Expected to close early in September quarter 0.7802 Each company’s stockholders will own appr

  18. Slide 18: Proforma Balance Sheet December 31, 2009

    Proforma Balance Sheet December 31, 2009 ($ in thousands) $152 Million in Cash and No Debt Current Assets Cash & cash equivalents 133,841 $ Marketable securities 11,607 Restricted cash Trade receivables 38,972 Other current assets 22,765 207,965 Restricted cash 5,560 Property & equipment 11,256 Good

  19. Slide 19: Proforma Income Statement – Pre Synergies

    Proforma Income Statement – Pre Synergies 9 Months Ended December 31, 2009 ($ in thousands) Annualized Revenue of ~ $170 million Geographic Split: NA-50%; EMEA-30%; APAC-20% Accelrys Symyx Pro Forma Adjustments Pro Forma Combined Revenue 62,200 66,858 - 129,058 Cost of revenue 10,896 19,822 (3,771)

  20. Slide 20: Timeline to Completion

    Timeline to Completion Filing of joint proxy statement SEC no review HSR clearance Record date ACCL Board Meeting ACCL Q4/YE earnings release East coast investor trip Jefferies Life Sciences conference (NY) Shareholder’s Meetings (ACCL & SMMX) Closing 5/18-19 5/24-25

  21. Slide 21: Focused Tactical Plan

    Focused Tactical Plan From May 10, 2010

  22. Slide 22: Accelrys, Inc. Forward-Looking Statements

    Accelrys, Inc. Investor Presentation May 2010 Max Carnecchia, CEO Michael Piraino, CFO Forward-Looking Statements Certain statements in this communication may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to

Symyx Technologies — Merger or Acquisition (May 2010) on 6ix